Menu

度他雄胺治疗前列腺增生效果怎么样?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Dutasteride is mainly used for the treatment of patients with prostatic hyperplasia (BPH). It can permanently improve the symptoms of BPH. Dutasteride can also reduce the incidence of prostate cancer. Dutasteride has been clinically used as a 5α reductase inhibitor to block this link to effectively treat prostatic hyperplasia (BPH). Dutasteride is an inhibitor of 5α reductase 2. (Dutasteride) can only inhibit 5α reductase 2 at clinically applied doses. How effective is dutasteride in treating prostatic hyperplasia?

In three two-year, placebo-controlled, double-blind, international multi-center clinical studies, the primary efficacy of 0.5 mg/day Dutasteride or placebo was evaluated in 4,325 men with benign prostatic hyperplasia (more than 30cc).

Compared with placebo, male patients with prostatic hyperplasia (BPH) treated with Dutasteride can reduce the risk of acute urinary retention (AUR) and the need for surgical intervention (SI), and can significantly improve lower urinary tract symptoms (LUTS), maximum urinary flow rate (Qmax) and prostate volume, and can treat and prevent disease progression. Within the first 24 months, improvements in LUTS, Qmax, and prostate volume were observed. In the follow-up 2-year open-label study, LUTS and Qmax continued to improve, and the prostate volume reduction continued to be maintained. Clinical studies of Dutasteride have shown that the therapeutic effect of this drug is very significant.

The above is an introduction to Dutasteride. If patients want to know more drug information about this drug, they can consult the medical companion service.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles:

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。